Literature DB >> 31889768

Two Threats to Precision Medicine Equity.

Dayna Bowen Matthew1.   

Abstract

In January 2015, President Barack Obama unveiled the "Precision Medicine Initiative," a nationwide research effort to help bring an effective, preventive, and therapeutic approach to medicine. The purpose of the initiative is to bring a precise understanding of the genetic and environmental determinants of disease into clinical settings across the United States.1 The announcement was coupled with $216 million provided in the President's proposed budget for a million-person national research cohort including public and private partnerships with academic medical centers, researchers, foundations, privacy experts, medical ethicists, and medical product innovators. The Initiative promises to expand the use of precision medicine in cancer research and modernize regulatory approval processes for genome sequencing technologies. In response, Congress passed the 21st Century Cures Act in December 2016, authorizing a total of $1.5 billion over 10 years for the program.2 Although the Precision Medicine Initiative heralds great promise for the future of disease treatment and eradication, its implementation and development must be carefully guided to ensure that the millions of federal dollars expended will be spent equitably. This commentary discusses two key threats to the Precision Medicine Initiative's ability to proceed in a manner consistent with the United States Constitutional requirement that the federal government shall not "deny to any person . . . the equal protection of the laws."3 In short, this commentary sounds two cautionary notes, in order to advance precision medicine equity. First, achieving precision medicine equity will require scientists and clinicians to fulfill their intellectual, moral, and indeed legal duty to work against abusive uses of precision medicine science to advance distorted views of racial group variation. Precision medicine scientists must decisively denounce and distinguish this Initiative from the pseudo-science of eugenics - the immoral and deadly pseudo-science that gave racist and nationalist ideologies what Troy Duster called a "halo of legitimacy" during the first half of the 20th century.4 Second, to combat the social threat to precision medicine, scientists must incorporate a comprehensive, ecological understanding of the fundamental social and environmental determinants of health outcomes in all research. Only then will the Precision Medicine Initiative live up to its potential to improve and indeed transform health care delivery for all patients, regardless of race, color, or national origin.
Copyright © 2019, Ethnicity & Disease, Inc.

Entities:  

Keywords:  Ecological Race; Equity; Eugenics; Racism

Mesh:

Year:  2019        PMID: 31889768      PMCID: PMC6919972          DOI: 10.18865/ed.29.S3.629

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   2.006


  38 in total

1.  Shattuck lecture--medical and societal consequences of the Human Genome Project.

Authors:  F S Collins
Journal:  N Engl J Med       Date:  1999-07-01       Impact factor: 91.245

2.  Why justice is good for our health: the social determinants of health inequalities.

Authors:  Norman Daniels; Bruce P Kennedy; Ichiro Kawachi
Journal:  Daedalus       Date:  1999

3.  The importance of race and ethnic background in biomedical research and clinical practice.

Authors:  Esteban González Burchard; Elad Ziv; Natasha Coyle; Scarlett Lin Gomez; Hua Tang; Andrew J Karter; Joanna L Mountain; Eliseo J Pérez-Stable; Dean Sheppard; Neil Risch
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

Review 4.  Personalized health care: from theory to practice.

Authors:  Ralph Snyderman
Journal:  Biotechnol J       Date:  2011-12-16       Impact factor: 4.677

5.  Stormy weather: race, gene expression, and the science of health disparities.

Authors:  Nancy Krieger
Journal:  Am J Public Health       Date:  2005-10-27       Impact factor: 9.308

6.  Willingness of minorities to participate in biomedical studies: confirmatory findings from a follow-up study using the Tuskegee Legacy Project Questionnaire.

Authors:  Ralph V Katz; B Lee Green; Nancy R Kressin; Cristina Claudio; Min Qi Wang; Stefanie L Russell
Journal:  J Natl Med Assoc       Date:  2007-09       Impact factor: 1.798

7.  Genomics, Health Disparities, and Missed Opportunities for the Nation's Research Agenda.

Authors:  Kathleen McGlone West; Erika Blacksher; Wylie Burke
Journal:  JAMA       Date:  2017-05-09       Impact factor: 56.272

8.  State of disparities in cardiovascular health in the United States.

Authors:  George A Mensah; Ali H Mokdad; Earl S Ford; Kurt J Greenlund; Janet B Croft
Journal:  Circulation       Date:  2005-03-15       Impact factor: 29.690

9.  No association between D2 dopamine receptor (DRD2) alleles or haplotypes and cocaine dependence or severity of cocaine dependence in European- and African-Americans.

Authors:  J Gelernter; H Kranzler; S L Satel
Journal:  Biol Psychiatry       Date:  1999-02-01       Impact factor: 13.382

10.  What if we were equal? A comparison of the black-white mortality gap in 1960 and 2000.

Authors:  David Satcher; George E Fryer; Jessica McCann; Adewale Troutman; Steven H Woolf; George Rust
Journal:  Health Aff (Millwood)       Date:  2005 Mar-Apr       Impact factor: 6.301

View more
  7 in total

1.  Precision Medicine Approaches to Health Disparities Research.

Authors:  Derek M Griffith
Journal:  Ethn Dis       Date:  2020-04-02       Impact factor: 1.847

Review 2.  One size does not fit all: an historian's perspective on precision diabetes medicine.

Authors:  Arleen M Tuchman
Journal:  Diabetologia       Date:  2022-02-08       Impact factor: 10.460

Review 3.  Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps.

Authors: 
Journal:  Nat Med       Date:  2021-11-15       Impact factor: 87.241

4.  National Maintenance Cost for Precision Diagnostics Under the Verifying Accurate Leading-Edge In Vitro Clinical Test Development (VALID) Act of 2020.

Authors:  Richard Huang; Laura Lasiter; Adam Bard; Bruce Quinn; Christina Young; Roberto Salgado; Jeff Allen; Jochen K Lennerz
Journal:  JCO Oncol Pract       Date:  2021-04-21

5.  Navigating Access to Cancer Care: Identifying Barriers to Precision Cancer Medicine.

Authors:  Kayla E Cooper; Khadijah E Abdallah; Rebekah S M Angove; Kathleen D Gallagher; Vence L Bonham
Journal:  Ethn Dis       Date:  2022-01-20       Impact factor: 2.006

Review 6.  How are social determinants of health integrated into epigenetic research? A systematic review.

Authors:  Linnea Evans; Michal Engelman; Alex Mikulas; Kristen Malecki
Journal:  Soc Sci Med       Date:  2021-02-03       Impact factor: 4.634

Review 7.  Understanding False Negative in Prenatal Testing.

Authors:  Mark I Evans; Ming Chen; David W Britt
Journal:  Diagnostics (Basel)       Date:  2021-05-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.